greeksoup/ stock research

AMETEK Inc.: Q1 FY2026 earnings call

What management said about Q1 FY2026, from the documents filed with the SEC on 30 April 2026: press release. Guidance figures: 3 raised, 3 new. The quarter’s numbers.

Key takeaways

  • Sales rose 11% to $1.93 billion: Net sales were $1,928.4 million against $1,732.0 million a year earlier. Management attributed earnings growth to organic sales growth and recent acquisitions. Source
  • Adjusted EPS rose 13% to $1.97: GAAP diluted EPS was a record $1.74, against $1.52. Adjusted diluted EPS was $1.97, against $1.75, after adding back $0.23 of after-tax amortization and integration costs. Source
  • EMG operating income up 33%: EMG operating income rose 33% to a record $170.8 million, from $128.7 million. Operating margin was 25.7%, up 380 basis points on the prior year. Source
  • Record orders up 23%: Orders rose 23% in the quarter to a record, and the company ended the quarter with a record backlog. Management described end-market demand as broad based. Source
  • Full-year sales guidance raised: Full-year 2026 sales are now expected to be up high single digits compared with 2025, up from mid to high single digits previously. Source
  • Full-year adjusted EPS guidance raised: Adjusted EPS range is $7.94 to $8.14, up 7% to 10% on 2025, from $7.87 to $8.07 previously. The GAAP EPS forecast moved to $7.03 to $7.23. Source
  • Second-quarter guidance issued: Second-quarter 2026 sales are expected up high single digits, and adjusted EPS is anticipated at $1.96 to $2.00, up 10% to 12% on the second quarter of 2025. Source

“AMETEK had an excellent start to the year. Strong organic sales growth, contributions from recent acquisitions, and outstanding operating performance led to double-digit earnings growth, record EBITDA and robust core margin expansion of 160 basis points,”

David A. Zapico, AMETEK Chairman and Chief Executive Officer

Guidance

AreaPeriodFigureAgainst last quarter
Sales SourceFull year 2026up high single digits compared to 2025Raised from up mid to high single digits compared to 2025
Adjusted diluted EPS SourceFull year 2026$7.94 to $8.14, up 7% to 10% over 2025Raised from $7.87 to $8.07
GAAP diluted EPS SourceFull year 2026$7.03 to $7.23Raised from $6.96 to $7.16
Sales SourceSecond quarter 2026up high single digits compared to the second quarter of 2025New
Adjusted diluted EPS SourceSecond quarter 2026$1.96 to $2.00, up 10% to 12% compared to the second quarter of 2025New
GAAP diluted EPS SourceSecond quarter 2026$1.73 to $1.77New

What changed from last quarter

  • Guidance raised: Full-year 2026 sales guidance moved from mid to high single digits growth to high single digits growth. Source
  • Guidance raised: Full-year 2026 adjusted EPS range raised to $7.94 to $8.14 from $7.87 to $8.07. Source
  • Guidance raised: Full-year 2026 GAAP diluted EPS forecast raised to $7.03 to $7.23 from $6.96 to $7.16. Source
  • New guidance: Second-quarter 2026 sales and adjusted EPS guidance added; the prior release gave only first-quarter guidance. Source

Results and growth drivers

  • Sales rose 11% to $1.93 billion: Net sales were $1,928.4 million against $1,732.0 million a year earlier. Management attributed earnings growth to organic sales growth and recent acquisitions. Source
  • Adjusted EPS rose 13% to $1.97: GAAP diluted EPS was a record $1.74, against $1.52. Adjusted diluted EPS was $1.97, against $1.75, after adding back $0.23 of after-tax amortization and integration costs. Source
  • Operating income and margin rose: GAAP operating income was $514.9 million. Adjusted operating income rose 14% to $516.6 million, and the release gives operating margin of 26.8%, up 50 basis points. Source
  • Record EBITDA and core margin gain: Management cited double-digit earnings growth, record EBITDA and core margin expansion of 160 basis points, from organic growth, acquisitions and operating performance. Source

Segment results

  • EIG sales up 11% to $1.26 billion: Electronic Instruments sales were $1,264.5 million, against $1,143.7 million, with organic growth and recent acquisitions contributing. Management described EIG orders growth as broad based. Source
  • EIG adjusted operating income up 6%: EIG segment operating income was $373.9 million GAAP and $375.6 million adjusted. Adjusted segment margin was 31.4%, up 40 basis points, and GAAP segment margin was 29.6%. Source
  • EMG sales a record $663.9 million: Electromechanical sales were $663.9 million, up 13% from $588.3 million. Management cited robust, broad-based organic sales growth in the segment. Source
  • EMG operating income up 33%: EMG operating income rose 33% to a record $170.8 million, from $128.7 million. Operating margin was 25.7%, up 380 basis points on the prior year. Source

“Additionally, end market demand remains strong and broad based, with record orders up 23% in the quarter resulting in a record backlog.”

David A. Zapico, AMETEK Chairman and Chief Executive Officer

Costs and margins

  • Cost of sales and SG&A rose: Cost of sales was $1,210.9 million, against $1,107.0 million. Selling, general and administrative expense was $202.6 million, against $170.2 million. Total operating expenses were $1,413.5 million. Source
  • Acquisition integration costs in cost of sales: Acquisition-related costs were $1.6 million, recorded as integration costs in cost of sales. The reconciliation adds $0.01 to diluted EPS for these costs. Source
  • Adjusted operating margin 27.9% versus 26.3%: The reconciliation table shows GAAP operating margin of 26.7% and adjusted margin of 27.9%, against 26.3% a year earlier. It adds 0.1 points of acquisition costs and 1.1 points of acquisition and currency dilution. Source

Demand and order book

  • Record orders up 23%: Orders rose 23% in the quarter to a record, and the company ended the quarter with a record backlog. Management described end-market demand as broad based. Source
  • Organic growth broad across EMG: Management said EMG's organic sales growth was robust and broad based, resulting in profit growth and sizeable margin expansion in the quarter. Source

Guidance for 2026 and Q2

  • Full-year sales guidance raised: Full-year 2026 sales are now expected to be up high single digits compared with 2025, up from mid to high single digits previously. Source
  • Full-year adjusted EPS guidance raised: Adjusted EPS range is $7.94 to $8.14, up 7% to 10% on 2025, from $7.87 to $8.07 previously. The GAAP EPS forecast moved to $7.03 to $7.23. Source
  • Second-quarter guidance issued: Second-quarter 2026 sales are expected up high single digits, and adjusted EPS is anticipated at $1.96 to $2.00, up 10% to 12% on the second quarter of 2025. Source

Capital, cash and balance sheet

  • Debt and cash position: Short-term borrowings and current debt were $1,114.9 million, against $1,209.0 million at December 31. Cash rose to $481.3 million from $458.0 million. Source
  • Dividends and diluted shares: Dividends per share were $0.34, against $0.31 a year earlier. Diluted weighted average shares were 229.8 million, against 231.5 million. Source
  • Receivables and inventories rose: Receivables were $1,154.0 million at March 31, against $1,119.3 million at December 31. Inventories were $1,143.4 million, against $1,106.4 million. Source

Strategy and acquisition capacity

  • Growth Model and niche markets: Management said AMETEK remains positioned on its record backlog, momentum across its markets and the AMETEK Growth Model, which integrates four growth strategies. Source
  • Acquisition capital available: Management said the balance sheet and cash flows provide meaningful capital to deploy on strategic acquisitions. Goodwill rose to $7,266.4 million from $7,170.8 million at year-end. Source

Coming up, as management said on 30 April 2026

  • Acquisition capital available: Management said the balance sheet and cash flows give the company capital to deploy on strategic acquisitions. The release names no specific transaction. Source
  • Second-quarter guidance set: Management expects second-quarter 2026 sales up high single digits compared with the second quarter of 2025. Source

Figures management reported

FigureReported
Orders growth Sourceup 23% in the quarter
Backlog Sourcerecord

Earlier plans management reported on

  • Not stated: The company states an objective of double-digit percentage EPS growth over the business cycle and a superior return on total capital. Source
  • Not stated: The prior release guided first-quarter sales up about 10%. The current release reports first-quarter sales up 11% and adjusted EPS of $1.97, without stating a comparison to that guidance.

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.